Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Burke

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Gastroenterology|October 19, 2021
Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritizationSanjay K Murthy, Lilia Antonova, Catherine Dube, et al.
Advances in Enzyme Regulation|January 8, 2008
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimizationJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Cancer Research|September 19, 2007
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptorsJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Journal of Molecular Biology|April 13, 2010
Effector cell recruitment with novel Fv-based dual-affinity re-targeting protein leads to potent tumor cytolysis and in vivo B-cell depletionSyd Johnson, Stephen Burke, Ling Huang, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Thorax|August 8, 2020
Lung Screen Uptake Trial: results from a single lung cancer screening roundMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
European Radiology|May 14, 2022
The role of computer-assisted radiographer reporting in lung cancer screening programmesHelen Hall, Mamta Ruparel, Samantha L Quaife, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Annals of the American Thoracic Society|March 14, 2020
Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening CohortMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
Thorax|September 28, 2019
Evaluation of cardiovascular risk in a lung cancer screening cohortMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Gastroenterology|October 19, 2021
Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritizationSanjay K Murthy, Lilia Antonova, Catherine Dube, et al.
Advances in Enzyme Regulation|January 8, 2008
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimizationJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Cancer Research|September 19, 2007
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptorsJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Journal of Molecular Biology|April 13, 2010
Effector cell recruitment with novel Fv-based dual-affinity re-targeting protein leads to potent tumor cytolysis and in vivo B-cell depletionSyd Johnson, Stephen Burke, Ling Huang, et al.
Arthritis and Rheumatism|May 28, 2010
Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffoldMaria-Concetta Veri, Stephen Burke, Ling Huang, et al.
Thorax|August 8, 2020
Lung Screen Uptake Trial: results from a single lung cancer screening roundMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
European Radiology|May 14, 2022
The role of computer-assisted radiographer reporting in lung cancer screening programmesHelen Hall, Mamta Ruparel, Samantha L Quaife, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Annals of the American Thoracic Society|March 14, 2020
Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening CohortMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
Thorax|September 28, 2019
Evaluation of cardiovascular risk in a lung cancer screening cohortMamta Ruparel, Samantha L Quaife, Jennifer L Dickson, et al.
Pageof 3